Literature DB >> 25596503

Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage.

Neeraj Badjatia1, Aimee Monahan2, Amanda Carpenter2, Jacqueline Zimmerman2, J Michael Schmidt2, Jan Claassen2, E Sander Connolly2, Stephan A Mayer2, Wahida Karmally2, David Seres2.   

Abstract

OBJECTIVE: To analyze the impact of inflammation and negative nitrogen balance (NBAL) on nutritional status and outcomes after subarachnoid hemorrhage (SAH).
METHODS: This was a prospective observational study of SAH patients admitted between May 2008 and June 2012. Measurements of C-reactive protein (CRP), transthyretin (TTR), resting energy expenditure (REE), and NBAL (g/day) were performed over 4 preset time periods during the first 14 postbleed days (PBD) in addition to daily caloric intake. Factors associated with REE and NBAL were analyzed with multivariable linear regression. Hospital-acquired infections (HAI) were tracked daily for time-to-event analyses. Poor outcome at 3 months was defined as a modified Rankin Scale score ≥ 4 and assessed by multivariable logistic regression.
RESULTS: There were 229 patients with an average age of 55 ± 15 years. Higher REE was associated with younger age (p = 0.02), male sex (p < 0.001), higher Hunt Hess grade (p = 0.001), and higher modified Fisher score (p = 0.01). Negative NBAL was associated with lower caloric intake (p < 0.001), higher body mass index (p < 0.001), aneurysm clipping (p = 0.03), and higher CRP:TTR ratio (p = 0.03). HAIs developed in 53 (23%) patients on mean PBD 8 ± 3. Older age (p = 0.002), higher Hunt Hess (p < 0.001), lower caloric intake (p = 0.001), and negative NBAL (p = 0.04) predicted time to first HAI. Poor outcome at 3 months was associated with higher Hunt Hess grade (p < 0.001), older age (p < 0.001), negative NBAL (p = 0.01), HAI (p = 0.03), higher CRP:TTR ratio (p = 0.04), higher body mass index (p = 0.03), and delayed cerebral ischemia (p = 0.04).
CONCLUSIONS: Negative NBAL after SAH is influenced by inflammation and associated with an increased risk of HAI and poor outcome. Underfeeding and systemic inflammation are potential modifiable risk factors for negative NBAL and poor outcome after SAH.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25596503      PMCID: PMC4336106          DOI: 10.1212/WNL.0000000000001259

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  43 in total

Review 1.  Mechanisms of acute brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Joshua B Bederson
Journal:  Neurol Res       Date:  2006-06       Impact factor: 2.448

2.  Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale.

Authors:  Jennifer A Frontera; Jan Claassen; J Michael Schmidt; Katja E Wartenberg; Richard Temes; E Sander Connolly; R Loch MacDonald; Stephan A Mayer
Journal:  Neurosurgery       Date:  2006-07       Impact factor: 4.654

3.  Energy provided by propofol infusion.

Authors:  Ted L Rice
Journal:  Am J Health Syst Pharm       Date:  2008-11-15       Impact factor: 2.637

4.  C-reactive protein and vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Flávio Ramalho Romero; Daniele Cristina Cataneo; Antonio José Maria Cataneo
Journal:  Acta Cir Bras       Date:  2014-05       Impact factor: 1.388

5.  Gender-specific differences in energy metabolism during the initial phase of critical illness.

Authors:  A Drolz; M Wewalka; T Horvatits; V Fuhrmann; B Schneeweiss; M Trauner; C Zauner
Journal:  Eur J Clin Nutr       Date:  2014-01-15       Impact factor: 4.016

6.  Nutrition support in the critically ill: a physician survey.

Authors:  Ami Shah Behara; Sarah J Peterson; Yimin Chen; John Butsch; Omar Lateef; Srinadh Komanduri
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 Mar-Apr       Impact factor: 4.016

7.  Inhibitory effects of eicosapentaenoic acid on chronic cerebral vasospasm after subarachnoid hemorrhage: possible involvement of a sphingosylphosphorylcholine-rho-kinase pathway.

Authors:  Satoshi Shirao; Hirosuke Fujisawa; Akira Kudo; Tetsu Kurokawa; Hiroshi Yoneda; Ichiro Kunitsugu; Kuniaki Ogasawara; Masaaki Soma; Sei Kobayashi; Akira Ogawa; Michiyasu Suzuki
Journal:  Cerebrovasc Dis       Date:  2008-05-30       Impact factor: 2.762

Review 8.  Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective.

Authors:  Pierre Singer; Haim Shapiro; Miryam Theilla; Ronit Anbar; Joelle Singer; Jonathan Cohen
Journal:  Intensive Care Med       Date:  2008-05-07       Impact factor: 17.440

Review 9.  Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America.

Authors:  Naomi P O'Grady; Philip S Barie; John G Bartlett; Thomas Bleck; Karen Carroll; Andre C Kalil; Peter Linden; Dennis G Maki; David Nierman; William Pasculle; Henry Masur
Journal:  Crit Care Med       Date:  2008-04       Impact factor: 7.598

10.  Does eicosapentaenoic acid (EPA) inhibit cerebral vasospasm in patients after aneurysmal subarachnoid hemorrhage?

Authors:  H Yoneda; S Shirao; T Kurokawa; H Fujisawa; S Kato; M Suzuki
Journal:  Acta Neurol Scand       Date:  2008-07       Impact factor: 3.209

View more
  23 in total

1.  Early Hypoalbuminemia is an Independent Predictor of Mortality in Aneurysmal Subarachnoid Hemorrhage.

Authors:  Réza Behrouz; Daniel A Godoy; Christopher Hans Topel; Lee A Birnbaum; Jean-Louis Caron; Ramesh Grandhi; Jeremiah N Johnson; Vivek Misra; Ali Seifi; Kathleen Urbansky; Mario Di Napoli
Journal:  Neurocrit Care       Date:  2016-10       Impact factor: 3.210

Review 2.  Nutritional and Bioenergetic Considerations in Critically Ill Patients with Acute Neurological Injury.

Authors:  Peter A Abdelmalik; Susan Dempsey; Wendy Ziai
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

Review 3.  Malnutrition in Stroke Patients: Risk Factors, Assessment, and Management.

Authors:  Toni Sabbouh; Michel T Torbey
Journal:  Neurocrit Care       Date:  2018-12       Impact factor: 3.210

4.  SIRT3 Expression Decreases with Reactive Oxygen Species Generation in Rat Cortical Neurons during Early Brain Injury Induced by Experimental Subarachnoid Hemorrhage.

Authors:  Wei Huang; Yong Huang; Ren-Qiang Huang; Cheng-Guang Huang; Wen-Hao Wang; Jin-Mao Gu; Yan Dong
Journal:  Biomed Res Int       Date:  2016-12-08       Impact factor: 3.411

5.  D-dimer may predict poor outcomes in patients with aneurysmal subarachnoid hemorrhage: a retrospective study.

Authors:  Jun-Hui Liu; Xiang-Kui Li; Zhi-Biao Chen; Qiang Cai; Long Wang; Ying-Hu Ye; Qian-Xue Chen
Journal:  Neural Regen Res       Date:  2017-12       Impact factor: 5.135

6.  Circular RNA hsa_circ_0021001 in peripheral blood: a potential novel biomarker in the screening of intracranial aneurysm.

Authors:  Lingfang Teng; Yu Chen; Huihui Chen; Xijun He; Junyou Wang; Yujiang Peng; Hongyu Duan; Huiyong Li; Da Lin; Bo Shao
Journal:  Oncotarget       Date:  2017-11-10

7.  Serum microRNAs are non-invasive biomarkers for the presence and progression of subarachnoid haemorrhage.

Authors:  Nian-Sheng Lai; Jia-Qi Zhang; Fei-Yun Qin; Bin Sheng; Xing-Gen Fang; Zhen-Bao Li
Journal:  Biosci Rep       Date:  2017-02-23       Impact factor: 3.840

8.  Serum glutamine and hospital-acquired infections after aneurysmal subarachnoid hemorrhage.

Authors:  Neeraj Badjatia; Serge Cremers; Jan Claassen; E Sander Connolly; Stephan A Mayer; Wahida Karmally; David Seres
Journal:  Neurology       Date:  2018-06-29       Impact factor: 9.910

9.  A pro-inflammatory mediator USP11 enhances the stability of p53 and inhibits KLF2 in intracerebral hemorrhage.

Authors:  Xiuqing Zhang; Tiejun Liu; Shijun Xu; Peng Gao; Wei Dong; Weiran Liu; Ming Gao; Lihua Song; Lusha Cui; Xiaoliu Dong
Journal:  Mol Ther Methods Clin Dev       Date:  2021-02-04       Impact factor: 6.698

10.  Neuromuscular Electrical Stimulation and High-Protein Supplementation After Subarachnoid Hemorrhage: A Single-Center Phase 2 Randomized Clinical Trial.

Authors:  Neeraj Badjatia; Stephanie Sanchez; Gabriella Judd; Rachel Hausladen; David Hering; Melissa Motta; Gunjan Parikh; Wendy Chang; Nicholas Morris; J Marc Simard; John Sorkin; George F Wittenberg; Alice S Ryan
Journal:  Neurocrit Care       Date:  2020-11-04       Impact factor: 3.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.